AHK-Cu vs GHK-Cu peptides: what the science actually supports

What did @pepkits.shop actually say?

The creator compared two copper peptides, GHK-Cu and AHK-Cu, in roughly 30 seconds. Their argument: GHK-Cu is the "social trend" peptide for skin and collagen, while AHK-Cu is "specifically for hair" because it "stimulates your hair follicles" to grow "thicker, richer hair" with better color. The punchline was a competitive sales pitch: AHK-Cu is "way stronger than GHK will ever be" for hair, and they claim to be "one out of two websites" selling it.

That last line is doing a lot of work. Framing scarcity as credibility is a marketing move, not a scientific argument. Let's separate what's actually defensible from what's being sold.

Does the science back this up?

Partly, but not cleanly. GHK-Cu has a genuine body of research behind it. AHK-Cu has some promising early data, but calling it definitively "stronger" overstates what the literature actually shows.

GHK-Cu (glycyl-L-histidyl-L-lysine copper) has decades of research across wound healing, collagen synthesis, and skin remodeling. Pickart et al. (2015, Cosmetics) documented its role in stimulating collagen and glycosaminoglycan synthesis. For hair specifically, Uno and Kurata (1993, Journal of Investigative Dermatology) found GHK-Cu increased hair follicle size and stimulated growth in animal models. It is not purely a "skin peptide."

AHK-Cu (alanyl-histidyl-lysine copper) has fewer published studies. Narda et al. (2019, Journal of Cosmetic Dermatology) compared AHK-Cu and GHK-Cu in a topical formulation, finding AHK-Cu showed stronger angiogenic activity and comparable or superior effects on some hair-related markers. That's meaningful, but one industry-adjacent study is not a consensus.

What did they get wrong (or right)?

They got the general direction right and some specifics wrong. Credit where it's due: AHK-Cu does have evidence suggesting particular activity at the hair follicle level, and GHK-Cu is genuinely associated with skin and collagen in most consumer marketing. That part of the comparison is fair.

What's wrong: saying GHK-Cu is not for hair is an overstatement. GHK-Cu has direct evidence for follicle stimulation. The creator's framing suggests GHK-Cu does skin and AHK-Cu does hair, but the receptor and signaling overlap is more complicated than that binary allows.

• The claim that AHK-Cu is "way stronger than GHK will ever be" for hair is not supported by the weight of evidence. One study showing comparable or slightly superior angiogenic markers is not the same as a proven superiority claim.
• Citing exclusivity as scientific credibility is a red flag. Scarcity on the retail market reflects regulatory complexity and supplier access, not validated efficacy.
• Neither peptide has been approved by the FDA for hair loss treatment. Topical copper peptides are sold as cosmetics or research compounds, not regulated therapeutics.

What should you actually know?

Both peptides work through copper-dependent signaling pathways and both have legitimate research interest for skin and hair applications. The distinction the creator draws is real but exaggerated.

If you're interested in copper peptides for hair, the honest summary is this: GHK-Cu has more published data overall. AHK-Cu has emerging data suggesting potentially stronger angiogenic and hair-follicle-specific activity. Neither has completed large-scale, randomized controlled trials in humans for hair growth as a primary endpoint. The Narda et al. (2019) study is often cited in this space and is worth reading, but it was a small, industry-connected study, not definitive proof.

Sourcing also matters. Copper peptides sold by small retailers without third-party testing, certificates of analysis, or transparent supply chains carry quality and purity risks that no amount of TikTok confidence covers. Before spending money based on a 30-second comparison video from a shop account, ask for documentation.

The regulatory reality

This video is being made by a seller, not a clinician or researcher. The claim of being "one out of two websites" that offer AHK-Cu should prompt questions, not trust. Legitimate telehealth and compounding contexts handle these peptides under physician oversight with documented sourcing. A TikTok shop is a different environment entirely, with no visible accountability layer between the product and the buyer.

Neither GHK-Cu nor AHK-Cu should be presented as a treatment for any medical condition, including androgenetic alopecia. If hair loss is a clinical concern, a licensed provider is the appropriate starting point, not a peptide vendor's social media page.